Global Cell Analysis Market
Market Size in USD Billion
CAGR :
%

![]() |
2023 –2030 |
![]() |
USD 18.41 Billion |
![]() |
USD 33.82 Billion |
![]() |
|
![]() |
|
Global Cell Analysis Market, By Product (Flow Cytometry Products, Qpcr Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, High-Content Screening Systems, Other Products), Process (Cell Identification, Cell Viability, Cell Signalling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, Single-Cell Analysis), End User (Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROS), Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, Other End Users) – Industry Trends and Forecast to 2030.
Cell Analysis Market Analysis and Size
According to the American Cancer Society, cancer is the second leading cause of death in the United States, trailing only heart disease. According to cancer statistics, 1.9 million new cancer cases are expected in the United States in 2022. Thus, the rising prevalence of cancer, as well as the never-ending research and development in this field, are expected to have a positive impact on industry growth.
Data Bridge Market Research analyses that the cell analysis market which is USD 18.41 billion in 2022, is expected to reach USD 33.82 billion by 2030, at a CAGR of 7.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cell Analysis Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Product (Flow Cytometry Products, Qpcr Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, High-Content Screening Systems, Other Products), Process (Cell Identification, Cell Viability, Cell Signalling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, Single-Cell Analysis), End User (Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROS), Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, Other End Users) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc (U.S.), Olympus Corporation (Japan), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Tecan Trading AG (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), BioStatus Limited (U.K.), NanoCellect Biomedical (U.S.) |
Market Opportunities |
|
Market Definition
Cell analysis is an umbrella term for a wide range of technologies used to study a cell's genetic and phenotypical characteristics. Its goal is to gain insights into the mechanisms of cellular functionality, which necessitates an understanding of cellular components such as DNA, RNA, protein content, and cellular metabolites. Cell analysis is commonly used to understand population heterogeneity, identify minority subpopulations of interest, and discover unique characteristics of individual cells. It also helps with gene and protein identification, epigenomics, and understanding the factors that govern cell health, proliferation, and death.
Cell Analysis Market Dynamics
Drivers
- Growing demand for analytical tools
The increasing demand for analytical tools for innovative research and subsequent funding has resulted in the introduction of high-throughput equipment. Multiple innovations have led to this equipment incorporating features such as automation, high sensitivity, and accuracy, all of which aid in the analysis of scarce samples. For instance, Deepcell Inc., a U.S.-based company, received USD 73 million in funding in March 2022 to accelerate and commercialize its AI-powered single cell analysis platform. As a result, key players are significantly investing in developing solutions, resulting in a lucrative revenue generation opportunity in the coming years.
Opportunities
- Technological advancements in cell analysis
The rising prevalence of chronic diseases and the development of advanced cancer therapies are driving technological advancements in cell analysis. For instance, Fluidigm Corporation, based in the United States, announced the launch of a REAP-seq (RNA expression and protein sequencing) platform that will aid researchers in understanding the mechanisms of cancer progression and immune response.
Restraints/Challenges
- High cost associated with instruments
Large costs associated with the use of instruments and complex and time-consuming guidelines will be some of the constraints that will hamper the cell analysis during the forecast period. The greatest challenge to the market's growth will be a lack of skilled professionals.
This cell analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Lifebit, a big data company based in the United Kingdom, announced a partnership with Boehringer Ingelheim. The collaboration will use Lifebit's Cloud OS, the first federated genomics platform, to build a data analytics infrastructure for Boehringer. This infrastructure will collect disease insights from biobanks in order to develop medicines.
- In 2021, SeqWell Inc. announced the release of the plexWell Single Cell Rapid Kit. The kit can be used for single-cell RNA sequencing as well as simplified NGS library preparation.
Global Cell Analysis Market Scope
The cell analysis market is segmented on the basis of product, process and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Flow Cytometry Products
- Reagents and Consumables
- Instruments
- Accessories
- Software
- Qpcr Products
- Reagents and Consumables
- Instruments
- Cell Microarrays
- Consumables
- Instruments
- Microscopes
- Electron Microscopes
- Inverted Microscopes
- Stereo Microscopes
- Fluorescence and Confocal Microscopes
- Phase-Contrast Microscopes
- Near-Field Scanning Optical Microscopes
- Other Microscopes
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Cell Counters
- Automated Cell Counters
- Hemocytometers
- Manual Cell Counters
- High-Content Screening Systems
- Other Products
Process
- Cell Identification
- Cell Viability
- Cell Signalling Pathway/Signal Transduction
- Cell Proliferation
- Cell Counting and Quality Control
- Cell Interaction
- Cell Structure Study
- Target Identification and Validation
- Single-Cell Analysis
End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROS)
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Cell Culture Collection Repositories
- Other End Users
Cell Analysis Market Regional Analysis/Insights
The cell analysis market is analyzed and market size insights and trends are provided by country, product, process and end user as referenced above.
The countries covered in the cell analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cell analysis market because of the prevalence of the business environment, increased government investment in drug discovery, and an increase in the number of research activities in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The cell analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell analysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Cell Analysis Market Share Analysis
The cell analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cell analysis market.
Some of the major players operating in the cell analysis market are:
- Danaher (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- BD (U.S.)
- General Electric (U.S.)
- Merck KGaA (Germany)
- Agilent Technologies, Inc (U.S.)
- Olympus Corporation (Japan)
- Promega Corporation (U.S.)
- PerkinElmer Inc. (U.S.)
- Tecan Trading AG (Switzerland)
- Miltenyi Biotec (Germany)
- Carl Zeiss AG (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Sysmex Corporation (Japan)
- BioStatus Limited (U.K.)
- NanoCellect Biomedical (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CELL ANALYSIS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE CELL ANALYSIS SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VOLUME DATA
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CELL ANALYSIS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 MERGERS AND ACQUISITIONS
10.8 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 PIPELINE ANALYSIS
12.1 CLINICAL TRIALS AND PHASE ANALYSIS
12.2 DRUG THERAPY PIPELINE
12.3 PHASE III CANDIDATES
12.4 PHASE II CANDIDATES
12.5 PHASE I CANDIDATES
12.6 OTHERS (PRE-CLINICAL AND RESEARCH)
TABLE 1 GLOBAL CLINICAL TRIAL MARKET FOR CELL ANALYSIS MARKET
Company Name Product Name
XX XX
XX XX
XX XX
XX XX
XX XX
XX XX
XX XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
TABLE 2 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE CELL ANALYSIS MARKET
Phase Number of Projects
Preclinical/Research Projects XX
Clinical Development XX
Phase I XX
Phase II XX
Phase III XX
U.S. Filed/Approved but Not Yet Marketed XX
Total XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
TABLE 3 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE FOR CELL ANALYSIS MARKET
Therapeutic Area Preclinical/ Research Project
XX XX
XX XX
XX XX
XX XX
XX XX
Total Projects XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
TABLE 4 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE FOR CELL ANALYSIS MARKET
Technology Preclinical/ Research Project
XX XX
XX XX
XX XX
XX XX
XX XX
Total Projects XX
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
FIGURE 1 TOP ENTITIES BASED ON R&D GLANCE FOR CELL ANALYSIS MARKET
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
13 REIMBURSEMENT FRAMEWORK
14 OPPUTUNITY MAP ANALYSIS
15 VALUE CHAIN ANALYSIS
16 HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
16.1 ECONOMIC DEVELOPMENT
17 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT
17.1 OVERVIEW
17.2 INSTRUMENTS
17.2.1 BY TYPE
17.2.1.1. PCR
17.2.1.1.1. DIGITAL PCR
17.2.1.1.2. REAL-TIME PCR
17.2.1.2. FLOW CYTOMETERS
17.2.1.2.1. CELL-BASED FLOW CYTOMETRY
17.2.1.2.2. BEAD-BASED FLOW CYTOMETRY
17.2.1.3. MICROSCOPES
17.2.1.3.1. OPTICAL
17.2.1.3.1.1 UPRIGHT
17.2.1.3.1.2 INVERTED
17.2.1.3.1.3 STEREOMICROSCOPES
17.2.1.3.1.4 PHASE CONTRAST
17.2.1.3.1.5 FLUORESCENCE
17.2.1.3.1.6 CONFOCAL SCANNING
17.2.1.3.1.7 NEAR FIELD SCANNING
17.2.1.3.1.8 OTHER OPTICAL MICROSCOPES
17.2.1.3.2. ELECTRON
17.2.1.3.2.1 SCANNING ELECTRON
17.2.1.3.2.2 TRANSMISSION
17.2.1.3.3. SCANNING PROBE
17.2.1.3.4. OTHERS
17.2.1.4. SPECTROPHOTOMETERS
17.2.1.4.1. MOLECULAR SPECTROMETRY
17.2.1.4.1.1 VISIBLE AND ULTRAVIOLET SPECTROSCOPY
17.2.1.4.1.2 INFRARED SPECTROSCOPY
17.2.1.4.1.3 NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY
17.2.1.4.1.4 OTHERS
17.2.1.4.2. MASS SPECTROMETRY (MS)
17.2.1.4.2.1 MALDI-TOF
17.2.1.4.2.2 TRIPLE QUADRUPOLE
17.2.1.4.2.3 QUADRUPOLE-TRAP
17.2.1.4.2.4 HYBRID LINEAR ION TRAP ORBITRAP
17.2.1.4.2.5 QUADRUPOLE-ORBITRAP
17.2.1.4.3. ATOMIC SPECTROMETRY
17.2.1.5. HEMOCYTOMETERS
17.2.1.5.1. DISPOSABLE
17.2.1.5.2. REUSABLE
17.2.1.6. CELL COUNTERS
17.2.1.7. CELL SORTER
17.2.1.7.1. MAGNETIC-ACTIVATED CELL SORTING (MACS) SYSTEM
17.2.1.7.2. OTHERS
17.2.1.8. MICROFLUIDIC DEVICES.
17.2.1.9. INCUBATORS
17.2.1.10. BIOSAFETY CABINETS
17.2.1.11. CENTRIFUGE
17.2.1.12. OTHERS
17.2.2 BY MODE
17.2.2.1. AUTOMATIC
17.2.2.2. MANUAL
17.2.3 BY MODALITY
17.2.3.1. BENCHTOP
17.2.3.2. PORTABLES
17.2.3.3. STANDALONE
17.2.3.4. OTHERS
17.3 CONSUMABLES
17.3.1 REAGENTS & KITS
17.3.2 STAINS & DYES
17.3.3 PROBES
17.3.4 BUFFERS & MEDIA
17.3.5 STANDARDS & CONTROLS
17.3.6 CELL DISSOCIATION REAGENTS
17.3.7 GLASS SLIDES AND COVERSLIPS.
17.3.8 MICROPLATES
17.3.9 BEADS
17.3.10 DISPOSABLES
17.3.11 OTHERS
18 GLOBAL CELL ANALYSIS MARKET, BY PROCESS
18.1 CELL IDENTIFICATION
18.2 CELL VIABILITY
18.3 CELL SIGNALLING PATHWAY/SIGNAL TRANSDUCTION
18.4 CELL PROLIFERATION
18.5 CELL COUNTING AND QUALITY CONTROL
18.6 CELL INTERACTION
18.7 CELL STRUCTURE STUDY
18.8 TARGET IDENTIFICATION AND VALIDATION
18.9 SINGLE-CELL ANALYSIS
18.1 OTHERS
19 GLOBAL CELL ANALYSIS MARKET, BY TECHNIQUE
19.1 OVERVIEW
19.2 NEXT-GENERATION SEQUENCING
19.2.1 WHOLE GENOME SEQUENCING
19.2.2 TARGETED SEQUENCING & RESEQUENCING
19.2.3 OTHERS
19.3 FLOW CYTOMETRY
19.4 POLYMERASE CHAIN REACTION
19.5 MICROSCOPY
19.6 SPECTROMETRY
19.7 MICROARRAY
19.8 OTHERS
20 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE
20.1 OVERVIEW
20.2 HUMAN CELLS
20.2.1 PRIMARY CELLS
20.2.2 STEM CELLS
20.2.3 DIFFERENTIATED CELLS
20.2.4 TUMOR CELLS
20.3 ANIMAL CELLS
20.3.1 PRIMARY CELLS
20.3.2 STEM CELLS
20.3.3 DIFFERENTIATED CELLS
20.3.4 TUMOR CELLS
20.4 MICROBIAL CELLS
20.4.1 PRIMARY CELLS
20.4.2 STEM CELLS
20.4.3 DIFFERENTIATED CELLS
20.4.4 TUMOR CELLS
20.5 PLANT CELLS
21 GLOBAL CELL ANALYSIS MARKET, BY APPLICATION
21.1 OVERVIEW
21.2 RESEARCH APPLICATIONS
21.2.1 BY TYPE
21.2.1.1. STEM CELL RESEARCH
21.2.1.2. CANCER RESEARCH
21.2.1.2.1. LUNG CANCER
21.2.1.2.2. STOMACH CANCER
21.2.1.2.3. COLORECTAL CANCER
21.2.1.2.4. BREAST CANCER
21.2.1.2.5. PROSTATE CANCER
21.2.1.2.6. LIVER CANCER
21.2.1.2.7. ESOPHAGUS CANCER
21.2.1.2.8. CERVICAL CANCER
21.2.1.2.9. KIDNEY CANCER
21.2.1.2.10. BLADDER CANCER
21.2.1.2.11. OTHERS
21.2.1.3. DRUG DISCOVERY & DEVELOPMENT
21.2.1.4. IMMUNOLOGY RESEARCH
21.2.1.5. NEUROBIOLOGY RESEARCH
21.2.1.6. CELL BIOLOGY RESEARCH
21.2.2 BY PRODUCT
21.2.2.1. INSTRUMENTS
21.2.2.2. CONSUMBALES
21.3 CLINICAL APPLICATIONS
21.3.1 BY TYPE
21.3.1.1. DISEASE DIAGNOSIS
21.3.1.2. HEMATOLOGY
21.3.1.3. ONCOLOGY
21.3.1.4. INFECTIOUS DISEASES
21.3.1.5. CARDIOLOGY
21.3.1.6. OTHERS
21.3.2 BY PRODUCT
21.3.2.1. INSTRUMENTS
21.3.2.2. CONSUMBALES
21.4 INDUSTRIAL APPLICATIONS
21.4.1 BY TYPE
21.4.1.1. BIOPROCESSING
21.4.1.2. QUALITY CONTROL
21.4.1.3. ENVIRONMENTAL TESTING
21.4.2 BY PRODUCT
21.4.2.1. INSTRUMENTS
21.4.2.2. CONSUMBALES
21.5 OTHERS
22 GLOBAL CELL ANALYSIS MARKET, BY END USER
22.1 OVERVIEW
22.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
22.2.1 BY TYPE
22.2.1.1. SMALL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
22.2.1.2. MEDIUM PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
22.2.1.3. ARGE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
22.2.2 BY PRODUCT
22.2.2.1. INSTRUMENTS
22.2.2.2. CONSUMABLES
22.3 ACADEMIC & RESEARCH INSTITUTES
22.3.1 BY PRODUCT
22.3.1.1. INSTRUMENTS
22.3.1.2. CONSUMBALES
22.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
22.4.1 BY PRODUCT
22.4.1.1. INSTRUMENTS
22.4.1.2. CONSUMBALES
22.5 DIAGNOSTIC LABORATORIES
22.5.1 BY PRODUCT
22.5.1.1. INSTRUMENTS
22.5.1.2. CONSUMBALES
22.6 HOSPITALS & CLINICAL TESTING LABS
22.6.1 BY PRODUCT
22.6.1.1. INSTRUMENTS
22.6.1.2. CONSUMBALES
22.7 CELL BANKS & BIOREPOSITORIES
22.7.1 BY PRODUCT
22.7.1.1. INSTRUMENTS
22.7.1.2. CONSUMBALES
22.8 GOVERNMENT & REGULATORY AGENCIES
22.8.1 BY PRODUCT
22.8.1.1. INSTRUMENTS
22.8.1.2. CONSUMBALES
22.9 OTHERS
23 GLOBAL CELL ANALYSIS MARKET, BY SALES CHANNEL
23.1 OVERVIEW
23.2 DIRECT TENDER
23.3 RETAIL SALES
23.3.1 OFFLINE
23.3.2 ONLINE
23.4 OTHERS
24 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY
GLOBAL CELL ANALYSIS MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 NORTH AMERICA
24.1.1 U.S.
24.1.2 CANADA
24.1.3 MEXICO
24.2 EUROPE
24.2.1 GERMANY
24.2.2 FRANCE
24.2.3 U.K.
24.2.4 ITALY
24.2.5 SPAIN
24.2.6 RUSSIA
24.2.7 TURKEY
24.2.8 BELGIUM
24.2.9 NETHERLANDS
24.2.10 SWITZERLAND
24.2.11 REST OF EUROPE
24.3 ASIA-PACIFIC
24.3.1 JAPAN
24.3.2 CHINA
24.3.3 SOUTH KOREA
24.3.4 INDIA
24.3.5 AUSTRALIA
24.3.6 SINGAPORE
24.3.7 THAILAND
24.3.8 MALAYSIA
24.3.9 INDONESIA
24.3.10 PHILIPPINES
24.3.11 REST OF ASIA-PACIFIC
24.4 SOUTH AMERICA
24.4.1 BRAZIL
24.4.2 ARGENTINA
24.4.3 PERU
24.4.4 CHILE
24.4.5 COLOMBIA
24.4.6 VENEZUELA
24.4.7 REST OF SOUTH AMERICA
24.5 MIDDLE EAST AND AFRICA
24.5.1 SOUTH AFRICA
24.5.2 SAUDI ARABIA
24.5.3 UAE
24.5.4 EGYPT
24.5.5 ISRAEL
24.5.6 REST OF MIDDLE EAST AND AFRICA
24.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
25 GLOBAL CELL ANALYSIS MARKET, COMPANY LANDSCAPE
25.1 COMPANY SHARE ANALYSIS: GLOBAL
25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
25.3 COMPANY SHARE ANALYSIS: EUROPE
25.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
25.5 MERGERS & ACQUISITIONS
25.6 NEW PRODUCT DEVELOPMENT & APPROVALS
25.7 EXPANSIONS
25.8 REGULATORY CHANGES
25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
26 GLOBAL CELL ANALYSIS MARKET, SWOT AND DBMR ANALYSIS
27 GLOBAL CELL ANALYSIS MARKET, COMPANY PROFILE
27.1 THERMO FISHER SCIENTIFIC INC.
27.1.1 COMPANY OVERVIEW
27.1.2 REVENUE ANALYSIS
27.1.3 GEOGRAPHIC PRESENCE
27.1.4 PRODUCT PORTFOLIO
27.1.5 RECENT DEVELOPEMENTS
27.2 BECTON, DICKINSON AND COMPANY
27.2.1 COMPANY OVERVIEW
27.2.2 REVENUE ANALYSIS
27.2.3 GEOGRAPHIC PRESENCE
27.2.4 PRODUCT PORTFOLIO
27.2.5 RECENT DEVELOPEMENTS
27.3 DANAHER CORPORATION
27.3.1 COMPANY OVERVIEW
27.3.2 REVENUE ANALYSIS
27.3.3 GEOGRAPHIC PRESENCE
27.3.4 PRODUCT PORTFOLIO
27.3.5 RECENT DEVELOPEMENTS
27.4 MERCK KGAA
27.4.1 COMPANY OVERVIEW
27.4.2 REVENUE ANALYSIS
27.4.3 GEOGRAPHIC PRESENCE
27.4.4 PRODUCT PORTFOLIO
27.4.5 RECENT DEVELOPEMENTS
27.5 AGILENT TECHNOLOGIES, INC.
27.5.1 COMPANY OVERVIEW
27.5.2 REVENUE ANALYSIS
27.5.3 GEOGRAPHIC PRESENCE
27.5.4 PRODUCT PORTFOLIO
27.5.5 RECENT DEVELOPEMENTS
27.6 BIO-RAD LABORATORIES, INC.
27.6.1 COMPANY OVERVIEW
27.6.2 REVENUE ANALYSIS
27.6.3 GEOGRAPHIC PRESENCE
27.6.4 PRODUCT PORTFOLIO
27.6.5 RECENT DEVELOPEMENTS
27.7 PERKINELMER, INC.
27.7.1 COMPANY OVERVIEW
27.7.2 REVENUE ANALYSIS
27.7.3 GEOGRAPHIC PRESENCE
27.7.4 PRODUCT PORTFOLIO
27.7.5 RECENT DEVELOPEMENTS
27.8 GE HEALTHCARE
27.8.1 COMPANY OVERVIEW
27.8.2 REVENUE ANALYSIS
27.8.3 GEOGRAPHIC PRESENCE
27.8.4 PRODUCT PORTFOLIO
27.8.5 RECENT DEVELOPEMENTS
27.9 ILLUMINA, INC.
27.9.1 COMPANY OVERVIEW
27.9.2 REVENUE ANALYSIS
27.9.3 GEOGRAPHIC PRESENCE
27.9.4 PRODUCT PORTFOLIO
27.9.5 RECENT DEVELOPEMENTS
27.1 ROCHE DIAGNOSTICS
27.10.1 COMPANY OVERVIEW
27.10.2 REVENUE ANALYSIS
27.10.3 GEOGRAPHIC PRESENCE
27.10.4 PRODUCT PORTFOLIO
27.10.5 RECENT DEVELOPEMENTS
27.11 PROMEGA CORPORATION
27.11.1 COMPANY OVERVIEW
27.11.2 REVENUE ANALYSIS
27.11.3 GEOGRAPHIC PRESENCE
27.11.4 PRODUCT PORTFOLIO
27.11.5 RECENT DEVELOPEMENTS
27.12 ABCAM PLC
27.12.1 COMPANY OVERVIEW
27.12.2 REVENUE ANALYSIS
27.12.3 GEOGRAPHIC PRESENCE
27.12.4 PRODUCT PORTFOLIO
27.12.5 RECENT DEVELOPEMENTS
27.13 MILTENYI BIOTEC
27.13.1 COMPANY OVERVIEW
27.13.2 REVENUE ANALYSIS
27.13.3 GEOGRAPHIC PRESENCE
27.13.4 PRODUCT PORTFOLIO
27.13.5 RECENT DEVELOPEMENTS
27.14 SARTORIUS AG
27.14.1 COMPANY OVERVIEW
27.14.2 REVENUE ANALYSIS
27.14.3 GEOGRAPHIC PRESENCE
27.14.4 PRODUCT PORTFOLIO
27.14.5 RECENT DEVELOPEMENTS
27.15 TECAN GROUP LTD.
27.15.1 COMPANY OVERVIEW
27.15.2 REVENUE ANALYSIS
27.15.3 GEOGRAPHIC PRESENCE
27.15.4 PRODUCT PORTFOLIO
27.15.5 RECENT DEVELOPEMENTS
27.16 CELL SIGNALING TECHNOLOGY, INC.
27.16.1 COMPANY OVERVIEW
27.16.2 REVENUE ANALYSIS
27.16.3 GEOGRAPHIC PRESENCE
27.16.4 PRODUCT PORTFOLIO
27.16.5 RECENT DEVELOPEMENTS
27.17 SYSMEX CORPORATION
27.17.1 COMPANY OVERVIEW
27.17.2 REVENUE ANALYSIS
27.17.3 GEOGRAPHIC PRESENCE
27.17.4 PRODUCT PORTFOLIO
27.17.5 RECENT DEVELOPEMENTS
27.18 OLYMPUS CORPORATION
27.18.1 COMPANY OVERVIEW
27.18.2 REVENUE ANALYSIS
27.18.3 GEOGRAPHIC PRESENCE
27.18.4 PRODUCT PORTFOLIO
27.18.5 RECENT DEVELOPMENTS.
27.19 TAKARA BIO INC.
27.19.1 COMPANY OVERVIEW
27.19.2 REVENUE ANALYSIS
27.19.3 GEOGRAPHIC PRESENCE
27.19.4 PRODUCT PORTFOLIO
27.19.5 RECENT DEVELOPEMENTS
27.2 AXION BIOSYSTEMS
27.20.1 COMPANY OVERVIEW
27.20.2 REVENUE ANALYSIS
27.20.3 GEOGRAPHIC PRESENCE
27.20.4 PRODUCT PORTFOLIO
27.20.5 RECENT DEVELOPEMENTS
27.21 EPPENDORF AG
27.21.1 COMPANY OVERVIEW
27.21.2 REVENUE ANALYSIS
27.21.3 GEOGRAPHIC PRESENCE
27.21.4 PRODUCT PORTFOLIO
27.21.5 RECENT DEVELOPEMENTS
27.22 BRUKER CORPORATION
27.22.1 COMPANY OVERVIEW
27.22.2 REVENUE ANALYSIS
27.22.3 GEOGRAPHIC PRESENCE
27.22.4 PRODUCT PORTFOLIO
27.22.5 RECENT DEVELOPEMENTS
27.23 QIAGEN N.V.
27.23.1 COMPANY OVERVIEW
27.23.2 REVENUE ANALYSIS
27.23.3 GEOGRAPHIC PRESENCE
27.23.4 PRODUCT PORTFOLIO
27.23.5 RECENT DEVELOPEMENTS
27.24 FLUIDIGM CORPORATION
27.24.1 COMPANY OVERVIEW
27.24.2 REVENUE ANALYSIS
27.24.3 GEOGRAPHIC PRESENCE
27.24.4 PRODUCT PORTFOLIO
27.24.5 RECENT DEVELOPEMENTS
27.25 BIO-TECHNE CORPORATION
27.25.1 COMPANY OVERVIEW
27.25.2 REVENUE ANALYSIS
27.25.3 GEOGRAPHIC PRESENCE
27.25.4 PRODUCT PORTFOLIO
27.25.5 RECENT DEVELOPEMENTS
27.26 CHARLES RIVER LABORATORIES
27.26.1 COMPANY OVERVIEW
27.26.2 REVENUE ANALYSIS
27.26.3 GEOGRAPHIC PRESENCE
27.26.4 PRODUCT PORTFOLIO
27.26.5 RECENT DEVELOPEMENTS
27.27 LUMINEX CORPORATION
27.27.1 COMPANY OVERVIEW
27.27.2 REVENUE ANALYSIS
27.27.3 GEOGRAPHIC PRESENCE
27.27.4 PRODUCT PORTFOLIO
27.27.5 RECENT DEVELOPEMENTS
27.28 SONY BIOTECHNOLOGY INC.
27.28.1 COMPANY OVERVIEW
27.28.2 REVENUE ANALYSIS
27.28.3 GEOGRAPHIC PRESENCE
27.28.4 PRODUCT PORTFOLIO
27.28.5 RECENT DEVELOPEMENTS
28 CONCLUSION
29 QUESTIONNAIRE
30 ABOUT DATA BRIDGE MARKET RESEARCH

Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.